Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging

NCT05826470 is registered in ClinicalTrials.gov with Genesis Research LLC as lead sponsor.

NCT NCT05826470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05826470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging
Lead sponsor
Genesis Research LLC
Phase
Not applicable
Overall status
Terminated
Start date
May 30, 2023
Completion date
December 5, 2024
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

low-risk or favorable intermediate risk prostate cancer who are on an active surveillance regimen, prostate cancer